Skip to main content
. 2019 Oct 23;8(18):7523–7531. doi: 10.1002/cam4.2634

Table 2.

Patient and tumor characteristics in the triple‐negative AC (TNAC) and IDC (TNBC) groups

Characteristic TNAC (N = 366) TNBC (N = 30 996) P‐value
n % n %  
Age (years)         <.001
18‐49 33 9.0 9072 29.3  
≥50 333 91.0 21 924 70.7  
Race         .001
White 265 72.4 21 881 70.6  
Black 51 13.9 6521 21.0  
Other 48 13.1 2406 7.8  
Unknown 2 0.5 188 0.6  
Marital status         .500
Married 185 50.5 16 622 53.6  
Unmarried 161 44.0 12 757 41.2  
Unknown 20 5.5 1617 5.2  
Laterality         .167
Left 170 46.4 15 925 51.4  
Right 196 53.6 15 067 48.6  
Unknown 0 0.0 4 0.0  
Tumor grade         <.001
I/II 242 66.1 5193 16.7  
III/IV 113 30.9 24 878 80.3  
Unknown 11 3.0 925 3.0  
T stage         <.001
T1 224 61.2 13 265 42.8  
T2 108 29.5 13 139 42.4  
T3 23 6.3 2657 8.6  
T4 11 3.0 1935 6.2  
N stage         .296
N0 250 68.3 19 755 63.7  
N1 83 22.7 7816 25.2  
N2 20 5.5 1919 6.2  
N3 13 3.6 1506 4.9  
Metastasis         .070
M0 355 97.0 29 417 94.9  
M1 11 3.0 1579 5.1  
AJCC stage         <.001
I 181 49.5 11 052 35.7  
II/III 174 47.5 18 365 59.2  
IV 11 3.0 1579 5.1  
Radiation therapy         .090
None/unknown 168 45.9 15 609 50.4  
Done 198 54.1 15 387 49.6  
Chemotherapy         <.001
None/unknown 134 36.6 7247 23.4  
Done 232 53.4 23 729 76.6  
Surgery         <.001
None 10 2.7 2487 8.0  
Done 356 97.3 28 509 92.0  

Abbreviations: AJCC, American Joint Committee on Cancer; TNAC, triple‐negative apocrine carcinoma; TNBC, triple‐negative breast cancer.